ARCT
Arcturus Therapeutics Holdings Inc
NASDAQ: ARCT · HEALTHCARE · BIOTECHNOLOGY
$8.40
-5.30% today
Updated 2026-04-29
Market cap
$238.75M
P/E ratio
—
P/S ratio
2.91x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$6 – $24
Volume
0.5M
Arcturus Therapeutics Holdings Inc (ARCT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-71.8%
Last 4 quarters
Revenue YoY growth
-85.3%
Most recent quarter
EPS YoY growth
+7.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-3.9%
2026-03-02
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $-1.03 | -124.1% | $8.23 | $7.91 | -3.9% |
| 2025-11-10 | $-0.49 | -108.9% | $8.72 | $8.67 | -0.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $4.28 | $-1.03 | -124.1% | $3.08M | -85.3% |
| 2025-09-30 | $5.53 | $-0.49 | -108.9% | $17.15M | -55.8% |
| 2025-06-30 | $3.21 | $-0.34 | -110.6% | $24.51M | -46.7% |
| 2025-03-31 | $-1.19 | $-0.52 | +56.3% | $29.38M | -9.9% |
| 2024-12-31 | $-0.49 | $-1.11 | -124.6% | $21.00M | -16.3% |
| 2024-09-30 | $-1.22 | $-0.26 | +78.7% | $38.81M | -10.5% |
| 2024-06-30 | $-1.60 | $-0.64 | +60.0% | $45.98M | +337.1% |
| 2024-03-31 | $-1.19 | $-1.00 | +16.0% | $32.60M | -59.4% |
| 2023-12-31 | $-0.99 | $-0.32 | +67.7% | $25.08M | — |
| 2023-09-30 | $-1.69 | $-0.61 | +63.9% | $43.38M | — |
| 2023-06-30 | $-0.21 | $-1.98 | -842.9% | $10.52M | — |
| 2023-03-31 | $0.06 | $1.87 | +3016.7% | $80.28M | — |
| 2022-12-31 | $0.98 | $4.43 | +352.0% | — | — |
Frequently asked questions
Has Arcturus Therapeutics Holdings Inc beaten earnings estimates?
Arcturus Therapeutics Holdings Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -71.8% over the last 4 quarters.
How does ARCT stock react to earnings?
ARCT stock has moved an average of -2.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Arcturus Therapeutics Holdings Inc's revenue growth rate?
Arcturus Therapeutics Holdings Inc reported year-over-year revenue growth of -85.3% in its most recent quarter, with EPS growing +7.2% year-over-year.